Form 4 Filing for Michael R. Megna

Michael R. Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc, reported a disposition of 6,625 Class A Ordinary Shares on April 9, 2026. The shares were sold at a price of $46.69 per share, totaling $309,174.25. This transaction was executed as part of a Rule 10b5-1 trading plan established on May 24, 2025. Following this transaction, Mr. Megna directly owns 27,418 Class A Ordinary Shares.